BONE TURNOVER CHANGES IN WOMEN TREATED WITH ELAGOLIX OR PLACEBO DURING THE ELARIS EM-I AND EM-II TRIALS WHO DID NOT CONTINUE IN THE EXTENSION STUDIES.

BONE TURNOVER CHANGES IN WOMEN TREATED WITH ELAGOLIX OR PLACEBO DURING THE ELARIS EM-I AND EM-II TRIALS WHO DID NOT CONTINUE IN THE EXTENSION STUDIES. Meeting Abstract

authors

Archer, David F.

publication date

September 1, 2018

webpage

Web of Science

published in

FERTILITY AND STERILITY Journal

start page

E12

end page

E12

volume

110

issue

4